These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 21047671)

  • 21. [Systemic sclerosis associated pulmonary arterial hypertension: the pitfalls].
    Hachulla E; Launay D; Le Pavec J; Mouthon L; Guillevin L; de Groote P
    Presse Med; 2011 Apr; 40 Suppl 1():1S46-53. PubMed ID: 21536180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
    Yuan YP; Yuan P; Su YL; Jiang R; Zhang R; He J; Qiu HL; Luo CJ; Liu JM; Gong SG; Wang L; Zhao QH
    Clin Rheumatol; 2022 Jun; 41(6):1675-1686. PubMed ID: 35099674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary hypertension in systemic sclerosis: different phenotypes.
    Launay D; Sobanski V; Hachulla E; Humbert M
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28954767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced systemic sclerosis complicated by pulmonary hypertension and complete atrioventricular block: a case report.
    Ciurzyński M; Bienias P; Szewczyk A; Lichodziejewska B; Błaszczyk M; Liszewska-Pfejfer D; Pruszczyk P
    Med Sci Monit; 2007 Oct; 13(10):CS124-7. PubMed ID: 17901856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.
    Hsu VM; Moreyra AE; Wilson AC; Shinnar M; Shindler DM; Wilson JE; Desai A; Seibold JR
    J Rheumatol; 2008 Mar; 35(3):458-65. PubMed ID: 18203320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome.
    Hachulla E; Launay D; Yaici A; Berezne A; de Groote P; Sitbon O; Mouthon L; Guillevin L; Hatron PY; Simonneau G; Clerson P; Humbert M;
    Rheumatology (Oxford); 2010 May; 49(5):940-4. PubMed ID: 20144930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.
    Proudman SM; Stevens WM; Sahhar J; Celermajer D
    Intern Med J; 2007 Jul; 37(7):485-94. PubMed ID: 17547726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension.
    Günther S; Jaïs X; Maitre S; Bérezné A; Dorfmüller P; Seferian A; Savale L; Mercier O; Fadel E; Sitbon O; Mouthon L; Simonneau G; Humbert M; Montani D
    Arthritis Rheum; 2012 Sep; 64(9):2995-3005. PubMed ID: 22549387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension.
    Schachna L; Medsger TA; Dauber JH; Wigley FM; Braunstein NA; White B; Steen VD; Conte JV; Yang SC; McCurry KR; Borja MC; Plaskon DE; Orens JB; Gelber AC
    Arthritis Rheum; 2006 Dec; 54(12):3954-61. PubMed ID: 17133609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The occurrence of pulmonary hypertension in patients with systemic sclerosis hospitalized in the Department of Rheumatology and Internal Diseases Medical University of Białystok in years 2003-2004.
    Gińdzieńska-Sieśkiewicz E; Kowal-Bielecka O; Kita J; Lisowska A; Domysławska I; Musiał W; Sierakowski S
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():297-300. PubMed ID: 16119691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of exercise pulmonary arterial hypertension in scleroderma.
    Callejas-Rubio JL; Moreno-Escobar E; de la Fuente PM; Pérez LL; Fernández RR; Sánchez-Cano D; Mora JP; Ortego-Centeno N
    J Rheumatol; 2008 Sep; 35(9):1812-6. PubMed ID: 18634147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension.
    Ruiz-Cano MJ; Escribano P; Alonso R; Delgado J; Carreira P; Velazquez T; Sanchez MA; Sáenz de la Calzada C
    J Heart Lung Transplant; 2009 Jun; 28(6):621-7. PubMed ID: 19481024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: similarities and differences.
    Montani D; Kemp K; Dorfmuller P; Sitbon O; Simonneau G; Humbert M
    Semin Respir Crit Care Med; 2009 Aug; 30(4):411-20. PubMed ID: 19634080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Strategy for early diagnosis of lung involvement in systemic scleroderma].
    Diot E; Valat C; Boissinot E; Giraudeau B; Asquier E; Guilmot JL; Lemarié E; Diot P
    Rev Mal Respir; 2000 Dec; 17(6):1073-80. PubMed ID: 11217502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease.
    Johnson SR; Granton JT; Tomlinson GA; Grosbein HA; Le T; Lee P; Seary ME; Hawker GA; Feldman BM
    J Rheumatol; 2012 Feb; 39(2):276-85. PubMed ID: 22247353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study.
    Overbeek MJ; Boonstra A; Voskuyl AE; Vonk MC; Vonk-Noordegraaf A; van Berkel MP; Mooi WJ; Dijkmans BA; Hondema LS; Smit EF; Grünberg K
    Arthritis Res Ther; 2011 Apr; 13(2):R61. PubMed ID: 21492463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension.
    Hagger D; Condliffe R; Woodhouse N; Elliot CA; Armstrong IJ; Davies C; Hill C; Akil M; Wild JM; Kiely DG
    Rheumatology (Oxford); 2009 Sep; 48(9):1137-42. PubMed ID: 19605369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lung impairment in systemic sclerosis].
    Knoop H; Arinir U; Kreuter A; Walther JW; Schultze-Werninghaus G; Rohde G
    Pneumologie; 2009 Sep; 63(9):497-507. PubMed ID: 19708006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.